Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — November 2022

Genmab — November 2022

Planlagt Fastgjort Låst Flyttet Genmab
1.0k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • G Offline
    G Offline
    gdn55
    wrote on sidst redigeret af
    #6

    Nå ,undskyld, så er der noget jeg har misforstået.

    1 Reply Last reply
    0
    • A Offline
      A Offline
      AaBforever
      wrote on sidst redigeret af
      #7

      Ok luk..2900

      1 Reply Last reply
      0
      • B Offline
        B Offline
        bikube
        wrote on sidst redigeret af
        #8

        Kursen "sitter fast", er der nogen der kan "åbn dn". (Monrad og Rislund).

        1 Reply Last reply
        0
        • P Offline
          P Offline
          ProinvestorNEWS
          wrote on sidst redigeret af
          #9

          Servicemeddelelse: Spændende nyt i Zealand Pharma-chatten.

          1 Reply Last reply
          0
          • P Offline
            P Offline
            ProinvestorNEWS
            wrote on sidst redigeret af
            #10

            Oversigt på dagens mange regnskaber.https://www.proinvestor.com/finanskalender

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #11

              -- TEPEZZA® (teprotumumab-trbw) Net Sales of $490.9 Million -- https://www.businesswire.com/news/home/20221031005857/en/Horizon-Therapeutics-plc-Reports-Third-Quarter-2022-Financial-Results-Increases-Full-Year-2022-Net-Sales-and-Adjusted-EBITDA-Guidance-Increases-TEPEZZA-and-KRYSTEXXA-Peak-Annual-Net-Sales-Expectations

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #12

                -- Increasing TEPEZZA Ex-U.S. Peak Annual Net Sales Expectations to Greater than $1 Billion, Bringing Global Peak Annual Net Sales Expectations to Greater than $4 Billion --

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #13

                  Today, the Company announced it is increasing its ex-U.S. peak annual net sales expectations for TEPEZZA to greater than $1 billion from the previous estimate of greater than $500 million, following further assessment of the ex-U.S. TED market opportunity and now also incorporating plans to launch TEPEZZA in Europe. The Company continues to expect U.S. peak annual net sales of greater than $3 billion, bringing global peak annual net sales expectations to greater than $4 billion.

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #14

                    The Company continues to expect TEPEZZA full-year 2022 net sales percentage growth in the high teens

                    1 Reply Last reply
                    0
                    • S Offline
                      S Offline
                      Sukkeralf
                      wrote on sidst redigeret af
                      #15

                      Not bad at all

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #16

                        market seems to like it, pre market HZNP +8%

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #17

                          https://www.novonordisk.com/content/dam/nncorp/global/en/investors/pdfs/financial-results/2022/Q3-2022-investor-presentation.pdf Novo presentation for Mim8

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #18

                            i can see no
                            late breaking abstract for SITC

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #19

                              GEN1056 starts recruiting. that is fast. in Moldova... https://clinicaltrials.gov/ct2/history/NCT05586321?A=1&B=2&C=merged#StudyPageTop

                              1 Reply Last reply
                              0
                              • G Offline
                                G Offline
                                gdn55
                                wrote on sidst redigeret af
                                #20

                                Vitus, hvordan går det?

                                1 Reply Last reply
                                0
                                • BulderB Offline
                                  BulderB Offline
                                  Bulder
                                  wrote on sidst redigeret af
                                  #21

                                  Hznp oppe med 11%

                                  1 Reply Last reply
                                  0
                                  • V Offline
                                    V Offline
                                    Vitus
                                    wrote on sidst redigeret af
                                    #22

                                    Det går helt som ventet…..Genmab er min guldåre….

                                    1 Reply Last reply
                                    0
                                    • BulderB Offline
                                      BulderB Offline
                                      Bulder
                                      wrote on sidst redigeret af
                                      #23

                                      Hm, US dykker kraftigt efter fed. Men både gmab og nvo (ads) holder sig oppe.

                                      1 Reply Last reply
                                      0
                                      • Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktør
                                        wrote on sidst redigeret af
                                        #24

                                        USA/lukning: Powell sendte aktierne i dørken efter kortvarigt plus https://www.proinvestor.com/investornyt/899194/usa-lukning-powell-sendte-aktierne-i-dorken-efter-kortvarigt-plus

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #25

                                          Godmorgen 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper